BGN and osteosarcoma: Transcription of the BGN, biglycan, promoter in bone cells was found to be increased due to elevated levels of intracellular cAMP, which in turn implicates cAMP/protein kinase-A signal transduction pathway in the regulation of biglycan gene expression in osteosarcoma [44].